What are the common barriers faced by patients in accessing long-acting injectable HIV prevention methods?
Evidence shows that economic, social, awareness, healthcare system, and cultural barriers significantly impact patient access to long-acting injectable HIV prevention methods. Addressing these barriers through policy, awareness, and systemic improvements can enhance uptake and equity in access.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-16
- DOI
- https://doi.org/10.5281/zenodo.24285778
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00